During the past several years, the field of immunology has expanded exponentially. Discoveries in basic immunology, molecular biology, genetics, cytokine biology, and transplantation have significantly advanced the discipline. Consequently, clinical laboratory immunology, a subspecialty of clinical pathology, has rapidly expanded and plays a pivotal role in the diagnosis and management of a wide variety of monogenic or other genetic causes of abnormal immune function. These encompass primary immunodeficiencies, which result in enhanced susceptibility to infections and increased predisposition to autoimmunity and malignancies, secondary immune deficiencies related to other diseases or therapies, and neoplastic transformation of lymphoid or other hematopoietic cells, as well as hyper-reactivity and dysregulation of the immune system to self (autoimmunity) or foreign substances (allergy). In addition, a thorough understanding of clinical laboratory immunology is essential to effectively manage solid organ and hematopoietic cell transplantation. The diagnostic evaluation of immune function and phenotype is also critical to the manipulation of the immune system through the use of biological and other pharmacologic immune response modifiers in various clinical contexts.
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Because of its critical position in the hospital setting, the clinical immunology laboratory is the "core" facility for immunologic testing of specimens from virtually every clinical subspecialty. It provides results and interpretations, is the resource for consultations with clinicians, and the reservoir of immunologic knowledge. 1 Thus, it is essential that the clinical immunology laboratory has a blueprint to follow regarding laboratory operations. As the field of basic and clinical immunology continues to expand with new discoveries and applications, only an appropriately trained individual can harness basic immunologic research findings and translate them into useful clinical laboratory applications. 2 Consequently, the clinical immunology laboratory director has the pivotal role of finding diagnostic solutions to clinical problems. He or she serves as the conduit for the translation of basic immunology knowledge into validated assays in the laboratory and for providing diagnostic consultations to clinical colleagues. While the clinical immunology practice is often subsumed into the general pathology or hematopathology disciplines in many medical centers, the rapid advances in the field and the complexity of clinical immunology necessitate specialized training and laboratory service to adequately address the growing needs of health care in the 21st century.
Knowledge and Techniques in Clinical Laboratory Immunology
The scope of clinical laboratory immunology is quite broad, with major implications for infectious disease, pediatrics, rheumatology, allergy and asthma, transplantation, nephrology, pulmonology, gastroenterology, neurology, cardiology, hematology, and oncology. Specific knowledge of the multitudinous components of the immune system, cellular interactions, and the function and physiology of the immune response are central to the practice of clinical laboratory immunology ❚Table 1❚. In addition, understanding the regulation of the immune response by other host systems such as those under neuroendocrine and metabolic control is essential to formulating new approaches to the diagnosis and management of immunologic diseases. Such knowledge is not typically presented in standard pathology residency training programs. Training in clinical laboratory immunology requires dedicated programs with specified durations for individuals with the appropriate foundational background in immunology to gain the additional skills required to translate basic knowledge into clinical laboratory practice. Such dedicated programs fulfill the stringent regulatory requirements associated with laboratory medicine and provide the necessary expertise to engage with clinicians in diagnostic consultations and guidance.
Laboratory evaluations using established and emerging techniques as well as concepts of immunology are essential for the diagnosis and management of immune-mediated disorders. Because of the inter-relationship between immunology and other laboratory disciplines such as chemistry, microbiology, and hematology, there exists some overlap in methodologic techniques and tests. ❚Table 2❚ presents specific immunologic analyses and technique(s) central to the clinical immunology laboratory. In some medical centers and reference hospitals/laboratories, serologic determination of antibodies to self-antigens and allergens is performed in clinical chemistry, immunophenotyping in hematopathology, and immunohistochemistry in anatomic pathology. Equipped with the foundational knowledge of normal and aberrant immune response, individuals trained in clinical laboratory immunology can effectively synthesize data obtained from these various laboratories into the appropriate clinical contexts. This is particularly important in the diagnosis and management of rare or complex diseases, such as primary immunodeficiencies, certain autoimmune disorders, and transplantation (organ or hematopoietic) cases where laboratory assays are required to assess immunophenotype, function, and response to treatment. [3] [4] [5] [6] Training also encompasses experience with specialized genetic tests that evaluate monogenic and polygenic immune disorders, flow cytometry, and other cellular techniques used to assess immune phenotype and function.
Assessment of biomarkers such as antibodies, cytokines, chemokines, and antigen-specific cells representing the diverse components of the immune system is a growing aspect of clinical laboratory immunology. 4 Moreover, the introduction of biologic therapies such as chimeric, humanized and human monoclonal antibodies, fusion proteins, and the assessment of immune response to these drugs presents the clinical immunology laboratory with novel opportunities for immune monitoring. 5 Likewise, assessment of cellmediated immune responses complements traditional in vivo delayed type hypersensitivity skin testing. Assays such as interferon gamma response assays are now commonly used for tuberculosis screening 6 and posttransplant monitoring of immune responsiveness. With the potential development of vaccines to treat chronic infections by engaging T-cell responses, monitoring antigen-specific T-cell function will likely become an integral component of tests offered in clinical immunology laboratories.
Relevance of Clinical Laboratory Immunology for Health Care in the 21st Century
The face of health care in the United States has changed and will continue to change with widespread implementation of the Affordable Healthcare Act. Recent estimates from the Office of the Actuary at the Centers of Medicare and Medicaid Services indicate that health care spending will steadily increase at an average annual rate of 5.8% between 2012 and 2022, thereby comprising approximately 20% of the gross domestic product by 2022. 7 Laboratory tests presently account for approximately 4% of health care costs and this share is projected to increase at an annual rate of 20% to 25%. However, coupled with this growth is proposed legislation that will decide the future of laboratory test reimbursements, with higher-volume tests targeted for reduced reimbursement bundling of tests on the hospital side of testing. The new reality of laboratory test reimbursements mandates a new approach and paradigm to diagnostic testing, such that the "value" component is satisfied. As good stewards of laboratory resources, laboratorians should ensure that value is obtained from diagnostic testing by advocating the right test for the right patient at the right time, performed in the right way. Thus, "value" in the diagnostic laboratory setting could be defined as outcomes plus service plus safety measured by cost over time. An optimal approach to diagnostic immunology testing is profoundly limited by a lack of understanding on the part of physicians in medical specialties of the complete scope and utility of the tests ordered. This problem is compounded both by the increased availability of an array of esoteric and complex immunology tests as well as the huge "information explosion" in the field of clinical immunology. The concept of test utilization necessitates a new role for the diagnostic immunologist/ laboratorian as an integrator, ie, gatekeeper and content expert, for the laboratory evaluation of immunologic diseases. Therefore, training programs and board certification directed specifically toward clinical laboratory immunology have immense value because these trained individuals will form the "new face" of laboratory testing in the 21st century health care environment.
Training and Certification of Medical Laboratory Immunologists
Clinical laboratory immunology is a unique subspecialty with limited or variable formal training in medical school and residency programs. It has traditionally been taught through "apprentice-type" tutelage, which lacks an organized curriculum with a strong element of research. Building on long-existing disease-and organ-specific medical practices, clinical laboratory immunology evolved from clinical subspecialties such as microbiology (infectious diseases), immune deficiencies, allergy, transplantation, [8] [9] [10] [11] [12] For pathologists, the specific level of technical expertise in training will vary with career goals as well as the emphasis of the particular program. 8, 9 The ABAI is a joint board of the American Board of Internal Medicine and the American Board of Pediatrics for physicians with a focus in clinical immunology: immunoregulation, immunotherapy, immunogenetics, and immunodiagnostics 10, 11 It is recognized that the focus on immunodiagnostic training will be programdependent and therefore the specific level of expertise will also vary. 11 For doctoral-level laboratory scientists in the United States, the two most common board certifications are through the ABCC with emphasis on chemistry, toxicology, or molecular diagnosis and ABMM for microbiology and public health laboratories. 9 In the specialty of histocompatibility testing, ASHI provides oversight of training programs and individual trainees via the Directors Training Review and Credentialing Committee. 12 The American Board of Medical Laboratory Immunologists (ABMLI), which is overseen by the committee on postdoctoral education programs (CPEP) of the American College of Microbiology, accredits training programs in medical laboratory immunology. 13 The CPEP medical immunology programs cover the field of diagnostic/ medical immunology in considerable breadth and depth: allergy, autoimmune disease serology, protein immunology including complement testing, cancer immunology, histocompatibility and immunogenetics (transplantation), primary and secondary immunodeficiencies, infectious disease serology, hematologic disorders, diagnostic methodologies (flow cytometry, molecular testing, etc), as well as laboratory management including informatics, regulation, research methods, and consultative aspects. ❚Table 3❚ shows the major areas of training and expected duration for each rotation as described in the CPEP Immunology Training Essentials for postgraduate trainees. 14 The following is a summary of the knowledge required:
• An in-depth understanding of specific immunologic concepts and how they relate to defined immunemediated diseases in the major training areas (Table 1 ).
• Proficiency in disease-specific classification criteria including analytical and diagnostic methods and their result interpretation (Table 2 ).
• Expertise in the development, evaluation, validation, and implementation of immunologic tests and their interpretation as well as methods for troubleshooting and standardizing performance for clinical use.
• Laboratory quality control and quality assurance programs as well as the theory and practice of laboratory safety including local, state, and federal regulations.
• Laboratory informatics, including learning about the use and availability of integrated software for preanalytical, analytical, and postanalytical components of diagnostic testing. Laboratory informatics training would also include the development of expertise in the use of specific data analysis tools required specifically for molecular diagnostics and flow cytometry. Both the laboratory quality control and informatics expertise would require dedicated training in biostatistics, especially as it relates to analysis of immunoassay, flow cytometry, and other diagnostic immunology data.
• Laboratory management including annual budget planning process, implementation of clinical studies, regulatory requirements on patient information confidentiality, limits on laboratory testing, data reporting, and proficiency testing.
• Communicative skills necessary to consult, teach, administer and/or manage the laboratory, and interact with professional peers.
• Development and implementation of a research protocol to address basic and/or applied immunology questions. The research methodology may also be applicable to development and regulatory requirements for "homebrew" assays.
Besides the course-specific materials governed by CPEP, the trainee is expected to meet other requirements mandated by The Accreditation Council for Graduate Medical Education. These include the medical knowledge required and the appropriate methods for diagnostic evaluation, patient care, and interpersonal and communication skills as well as a Also includes laboratory safety, management, regulations, quality management, automation, and specimen collection. b Also includes communication and clinical consultation. Appropriate instruction must be made available through bench training and experience, clinical conferences, hospital rounds, workshops, organized courses, self-instructional materials, and administrative training. Emphasis must be placed on laboratory diagnostic practice and clinical experience. 11 Individual training programs may increase the amount of time devoted to specific sub-areas, depending on the duration of the program (minimum of 2 years), but could be longer, depending on the institution and availability of funding.
professionalism and systems-based practice. The programs are actively monitored to ensure continued excellence in training and are subject to onsite inspections every 7 years to obtain reaccreditation. 15 Individuals may obtain training outside an accredited program that meets requirements for board certification. Laboratories may hire individuals and provide experience in the broad range of diagnostic immunology methods and clinical exposure necessary for board certification. Proficiency may also be acquired in a clinical or translational research setting under the supervision of a trained clinical immunologist if the breadth and depth of experience meet the requirements and recommendations of the credentialing committee of the ABMLI. 16 In addition to formal training in diagnostic immunology through the aforementioned programs, there is a distinct and essential role for continuing education provided by subspecialty professional societies such as the International Clinical Cytometry Society (cellular immunology and hematology-related flow cytometry testing); the Clinical and Diagnostic Immunology Division of the American Association of Clinical Chemistry, which includes but is not limited to immunoassays for autoimmune and infectious disease serology and flow cytometry; the Clinical Immunology Society (facilitates interaction between laboratory and clinical immunologists); and the Association of Medical Laboratory Immunologists (offers periodic training courses and web-based educational tools for diagnostic immunology).
Board Certification
For doctoral-level scientists, board certification is required to serve as a laboratory director under the Clinical Laboratory Improvement Amendment 1988 (CLIA 88). Although several boards are available that are recognized by federal guidelines ❚Table 4❚, ABMLI is the only board that specializes in verifying the training and experience of laboratory immunologists. 16, 17 Interested persons qualify to take the ABMLI after completing 2 years of postdoctoral training in an accredited training program (plan A), 1 year of postdoctoral training in an accredited training program following 2 years of acceptable postdoctoral experience (plan B), or 3 years of appropriate postdoctoral experience in clinical laboratory immunology (plan C). 16 The ABMLI was established in 1975 for doctoral-level immunologists and designed to formally validate a candidate's knowledge, problem-solving abilities, and clinical judgment in subject areas considered necessary for the practice of clinical immunology and the directorship of a clinical immunology laboratory. Most regulatory agencies and several states in the United States require nonmedical laboratory directors possessing a PhD degree to have board certification or credentials establishing competence to serve as a laboratory director. The ABMLI certification is recognized by federal CLIA 88 laws and states that require licensure: Florida, Georgia, Hawaii, Louisiana, Montana, Nevada, New York, North Dakota, Rhode Island, Tennessee, and West Virginia. 13 The other board certification recognized by the US Department of Health and Human Services is the American Board of Histocompatibility and Immunogenetics for specialization in immunology-based histocompatibility testing. 17 
Opportunities for ABMLI Laboratory Immunologists
ABMLI certification offers unique opportunities to a trained immunologist. One career path is becoming a director of a clinical immunology laboratory. Academic medical centers offer additional professional opportunities for welltrained and credentialed immunologists to direct diagnostic operations, conduct clinical trials, perform basic research, and assume a consultative role for caregivers. Employment in a commercial reference laboratory is another career 
The Future of Clinical Laboratory Immunology Remains Positive
The pace of change in the discipline of immunology in this second decade of the 21st century is unprecedented. As noted by the president of Harvard University, Drew Gilpin Faust, "change is constant, endemic and necessary." 18 Facilitated by an explosion of technical advances in genomics, proteomics, and systems biology, this rate of change is only expected to accelerate. 19, 20 As the field of clinical immunology continues to advance, there will always remain a need for well-trained, board-certified postdoctoral clinical laboratory immunologists.
Given the pace of scientific breakthroughs in medicine, several training programs have already recognized the need to diversify and intensify their training curriculum to meet the demands of their professions. 19, 21 These programs offer valuable insights to those involved in training and credentialing clinical laboratory immunologists. Access to accredited training programs with up-to-date curricula, professional mentoring, and awareness of employment avenues and prospects is crucial to the progress of the discipline. As John Fahey wrote over a decade ago in his commentary on Clinical Laboratory Immunology: The Future, "Adventure, rewards and indeed, pleasure will be there for those who are prepared and are fortunate enough to have the resources to participate in the clinical laboratory immunology of the future." 22 The face of clinical laboratory immunology has changed significantly in the intervening decade since that commentary was written. It will continue to change, and the need to have properly trained and certified individuals in diagnostic immunology will continue to grow.
